BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34386002)

  • 1.
    Buhelt S; Laigaard HM; von Essen MR; Ullum H; Oturai A; Sellebjerg F; Søndergaard HB
    Front Immunol; 2021; 12():676141. PubMed ID: 34386002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of systemic inflammation, soluble IL-2Rα and the multiple sclerosis-associated IL2RA SNP rs2104286 in healthy subjects and multiple sclerosis patients.
    Buhelt S; Søndergaard HB; Mahler MR; Cobanovic S; Börnsen L; Ammitzbøll C; Oturai AB; Sellebjerg F
    Mult Scler Relat Disord; 2021 Sep; 54():103140. PubMed ID: 34304016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Multiple Sclerosis-Associated
    Buhelt S; Søndergaard HB; Oturai A; Ullum H; von Essen MR; Sellebjerg F
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between soluble CD25 and gene expression in healthy individuals and patients with multiple sclerosis.
    Buhelt S; Ratzer RL; Christensen JR; Börnsen L; Sellebjerg F; Søndergaard HB
    Cytokine; 2017 May; 93():15-25. PubMed ID: 28511943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic link between CXCR5 and IL2RA gene polymorphisms and susceptibility to multiple sclerosis.
    Xia ZL; Qin QM; Zhao QY
    Neurol Res; 2018 Dec; 40(12):1040-1047. PubMed ID: 30352019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A variant of the Il2ra / Cd25 gene predisposing to graves' disease is associated with increased levels of soluble interleukin-2 receptor.
    Chistiakov DA; Chistiakova EI; Voronova NV; Turakulov RI; Savost'anov KV
    Scand J Immunol; 2011 Nov; 74(5):496-501. PubMed ID: 21815908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis.
    Wang LM; Zhang DM; Xu YM; Sun SL
    J Int Med Res; 2011; 39(5):1625-35. PubMed ID: 22117963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.
    Maier LM; Anderson DE; Severson CA; Baecher-Allan C; Healy B; Liu DV; Wittrup KD; De Jager PL; Hafler DA
    J Immunol; 2009 Feb; 182(3):1541-7. PubMed ID: 19155502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA.
    Du J; Wang X; Tan G; Wei W; Zhou F; Liang Z; Li H; Yu H
    J Mol Med (Berl); 2021 Oct; 99(10):1487-1495. PubMed ID: 34287665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk.
    Wang XX; Chen T
    Immunol Invest; 2018 Jul; 47(5):431-442. PubMed ID: 29648897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL2RA is associated with persistence of rheumatoid arthritis.
    van Steenbergen HW; van Nies JA; Ruyssen-Witrand A; Huizinga TW; Cantagrel A; Berenbaum F; van der Helm-van Mil AH
    Arthritis Res Ther; 2015 Sep; 17(1):244. PubMed ID: 26350950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor α chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese.
    Ainiding G; Kawano Y; Sato S; Isobe N; Matsushita T; Yoshimura S; Yonekawa T; Yamasaki R; Murai H; Kira J;
    J Neurol Sci; 2014 Feb; 337(1-2):147-50. PubMed ID: 24332945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL2RA Allele Increases Risk of Neuromyelitis Optica in Southern Han Chinese.
    Dai Y; Li J; Zhong X; Wang Y; Qiu W; Lu Z; Wu A; Bao J; Peng F; Hu X
    Can J Neurol Sci; 2013 Nov; 40(6):832-5. PubMed ID: 24257225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis.
    Field J; Fox A; Jordan MA; Baxter AG; Spelman T; Gresle M; Butzkueven H; Kilpatrick TJ; Rubio JP
    Genes Immun; 2017 Mar; 18(2):59-66. PubMed ID: 28077880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).
    Alcina A; Fedetz M; Ndagire D; Fernández O; Leyva L; Guerrero M; Abad-Grau MM; Arnal C; Delgado C; Lucas M; Izquierdo G; Matesanz F
    PLoS One; 2009; 4(1):e4137. PubMed ID: 19125193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: possible parallel pathways?
    Lindner E; Weger M; Steinwender G; Griesbacher A; Posch U; Ulrich S; Wegscheider B; Ardjomand N; El-Shabrawi Y
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8295-9. PubMed ID: 21911588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk.
    Cavanillas ML; Alcina A; Núñez C; de las Heras V; Fernández-Arquero M; Bartolomé M; de la Concha EG; Fernández O; Arroyo R; Matesanz F; Urcelay E
    Eur J Hum Genet; 2010 Jul; 18(7):794-9. PubMed ID: 20179739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms and haplotypes of IL2RA, IL10, IFNG, IRF5, and CCR2 are associated with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Tang N; Huang J; Chen C; Wu X; Xu H; Chen G; Xue H
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29097. PubMed ID: 34031980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.